Nicole Sweeny's most recent trade in Praxis Precision Medicines Inc was a trade of 1,456 Common Stock done at an average price of $3.9 . Disclosure was reported to the exchange on Feb. 12, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Praxis Precision Medicines... | Nicole Sweeny | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.94 per share. | 12 Feb 2023 | 1,456 | 38,619 | - | 3.9 | 5,737 | Common Stock |
Praxis Precision Medicines... | Nicole Sweeny | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2023 | 120,000 | 120,000 | - | - | Stock Option (Right to Buy) | |
Praxis Precision Medicines... | Nicole Sweeny | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2023 | 41,085 | 41,085 | - | - | Stock Option (Right to Buy) | |
Praxis Precision Medicines... | Nicole Sweeny | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.52 per share. | 07 Jan 2023 | 2,079 | 40,075 | - | 2.5 | 5,239 | Common Stock |
Praxis Precision Medicines... | Nicole Sweeny | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
Praxis Precision Medicines... | Nicole Sweeny | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 8.80 per share. | 13 May 2022 | 2,587 | 42,154 | - | 8.8 | 22,760 | Common Stock |
Praxis Precision Medicines... | Nicole Sweeny | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.85 per share. | 12 Feb 2022 | 1,233 | 39,567 | - | 12.8 | 15,844 | Common Stock |
Praxis Precision Medicines... | Nicole Sweeny | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 84,000 | 84,000 | - | - | Stock Option (Right to Buy) | |
Praxis Precision Medicines... | Nicole Sweeny | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 24,000 | 40,800 | - | 0 | Common Stock | |
Praxis Precision Medicines... | Nicole Sweeny | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2021 | 58,880 | 58,880 | - | - | Stock Option (Right to Buy) | |
Praxis Precision Medicines... | Nicole Sweeny | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2021 | 16,800 | 16,800 | - | 0 | Common Stock |